Get complete Patent Opposition Report for Miltenyi Biotec

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Miltenyi Biotec

Explore patent oppositions filed by Miltenyi Biotec against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3696277Quantitative Dna-Based Imaging And Super-Resolution ImagingPRESIDENT AND FELLOWS OF HARVARD COLLEGESep 8, 2023
EP3247808Point-Of-Care And/Or Portable Platform For Gene TherapyFRED HUTCHINSON CANCER RESEARCH CENTERFeb 1, 2022
EP3237442CellAUTOLUSApr 8, 2020
EP3214091Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJul 2, 2019
EP2734538Method Of Reversibly Staining A Target CellIBAFeb 1, 2019
EP2782997Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical ApplicationsGENETHONOct 9, 2018
EP2651978Use Of An Antibody Directed Against A Membrane ProteinLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESFeb 9, 2018

Explore Miltenyi Biotec's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3134512Jan 2, 2019Method For Automated Generation Of Genetically Modified T Cells6
EP3025719Sep 26, 2018Combination Immunotherapy Of Antigen-Recognizing Receptors And Hematopoietic Cells For The Treatment Of Diseases2